Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan
- DOI
- 10.1007/s12325-023-02564-4
- Published
- 2023-06-12
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-023-02564-4,
title = {Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan},
author = {Naoki Hosogaya and Takahiro Takazono and Kenji Kurazono and Shinzo Hiroi and Kosuke Iwasaki and Tomomi Takeshima and Chise Ha and Hiroshi Mukae},
year = {2023},
journal = {Advances in Therapy},
doi = {10.1007/s12325-023-02564-4},
url = {https://doi.org/10.1007/s12325-023-02564-4}
}RIS
TY - JOUR TI - Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan AU - Naoki Hosogaya AU - Takahiro Takazono AU - Kenji Kurazono AU - Shinzo Hiroi AU - Kosuke Iwasaki AU - Tomomi Takeshima AU - Chise Ha AU - Hiroshi Mukae PY - 2023 JO - Advances in Therapy DO - 10.1007/s12325-023-02564-4 UR - https://doi.org/10.1007/s12325-023-02564-4 ER -
APA
Hosogaya, N., Takazono, T., Kurazono, K., Hiroi, S., Iwasaki, K., Takeshima, T., Ha, C., & Mukae, H. (2023). Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan. Advances in Therapy. https://doi.org/10.1007/s12325-023-02564-4
Source records
- crossref · retrieved 2026-09-27T11:57:56.824Z